PT1248618E - Formas polimorficas, amorfas e hidratadas de 5-cloro-3-(4-metanossulfonilfenil)-6'-metil-[2,3']bipiridinilo - Google Patents
Formas polimorficas, amorfas e hidratadas de 5-cloro-3-(4-metanossulfonilfenil)-6'-metil-[2,3']bipiridiniloInfo
- Publication number
- PT1248618E PT1248618E PT00980817T PT00980817T PT1248618E PT 1248618 E PT1248618 E PT 1248618E PT 00980817 T PT00980817 T PT 00980817T PT 00980817 T PT00980817 T PT 00980817T PT 1248618 E PT1248618 E PT 1248618E
- Authority
- PT
- Portugal
- Prior art keywords
- polymorphic
- methanosulphonylphenyl
- amorfas
- bipyridinyl
- hydrate
- Prior art date
Links
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16792299P | 1999-11-29 | 1999-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1248618E true PT1248618E (pt) | 2006-07-31 |
Family
ID=22609368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00980817T PT1248618E (pt) | 1999-11-29 | 2000-11-27 | Formas polimorficas, amorfas e hidratadas de 5-cloro-3-(4-metanossulfonilfenil)-6'-metil-[2,3']bipiridinilo |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6441002B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1248618B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4425514B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE320809T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU776544B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2391650C (cg-RX-API-DMAC7.html) |
| DE (1) | DE60026877T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1248618T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2259295T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1248618E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001037833A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
| US6521642B2 (en) * | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
| WO2005085199A1 (en) * | 2004-01-14 | 2005-09-15 | Cadila Healthcare Limited | Novel polymorphs of etoricoxib |
| HUE028730T2 (en) | 2009-02-27 | 2017-01-30 | Cadila Healthcare Ltd | Process for the preparation of etoricoxib |
| WO2012163839A1 (en) | 2011-05-27 | 2012-12-06 | Farma Grs, D.O.O. | A process for the preparation of polymorphic form i of etoricoxib |
| EP2773618A1 (en) | 2011-11-03 | 2014-09-10 | Cadila Healthcare Limited | An improved process for the preparation of etoricoxib and polymorphs thereof |
| WO2013075732A1 (en) | 2011-11-21 | 2013-05-30 | Synthon Bv | Process for making crystalline form i of etoricoxib |
| EP2601952A1 (en) | 2011-12-07 | 2013-06-12 | Zentiva, k.s. | Novel pharmaceutically acceptable salts and cocrystals of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl and their therapeutic uses |
| EP2831045A2 (en) * | 2012-03-30 | 2015-02-04 | Mylan Laboratories, Limited | An improved process for the preparation of etoricoxib |
| WO2014041558A2 (en) | 2012-08-27 | 2014-03-20 | Glenmark Pharmaceuticals Limited; Glenmark Generics Limited | Process for preparation of crystalline etoricoxib |
| CN104418799A (zh) * | 2013-09-03 | 2015-03-18 | 天津药物研究院 | 一种依托考昔的晶型及其制备方法和应用 |
| WO2015036550A1 (en) | 2013-09-13 | 2015-03-19 | Synthon B.V. | Process for making etoricoxib |
| CN107056691B (zh) * | 2017-06-21 | 2020-03-10 | 四川尚锐生物医药有限公司 | 一种制备依托考昔晶型v的方法 |
| WO2019130049A1 (en) | 2017-12-29 | 2019-07-04 | Grünenthal GmbH | Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain |
| CN111410629A (zh) * | 2020-03-31 | 2020-07-14 | 天津大学 | 依托考昔溶剂化物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5321033A (en) | 1991-11-15 | 1994-06-14 | Merck Frosst Canada, Inc. | Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases |
| SI0912518T1 (en) | 1996-07-18 | 2003-12-31 | Merck Frosst Canada & Co. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| US6130334A (en) | 1998-04-15 | 2000-10-10 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
| US6127545A (en) | 1997-04-18 | 2000-10-03 | Merck & Co., Inc. | Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 inhibitors |
| US6040450A (en) | 1997-09-25 | 2000-03-21 | Merck & Co., Inc. | Process for making diaryl pyridines useful as cox-2-inhibitors |
| UA57143C2 (uk) | 1998-04-24 | 2003-06-16 | Мерк Енд Ко., Інк. | Спосіб синтезу інгібіторів сох-2 (циклооксигенази-2) та проміжні сполуки для їх одержання |
| PH12001001175B1 (en) * | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
| US6521642B2 (en) * | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
-
2000
- 2000-11-27 CA CA2391650A patent/CA2391650C/en not_active Expired - Lifetime
- 2000-11-27 AT AT00980817T patent/ATE320809T1/de active
- 2000-11-27 WO PCT/US2000/032353 patent/WO2001037833A1/en not_active Ceased
- 2000-11-27 PT PT00980817T patent/PT1248618E/pt unknown
- 2000-11-27 ES ES00980817T patent/ES2259295T3/es not_active Expired - Lifetime
- 2000-11-27 AU AU18031/01A patent/AU776544B2/en not_active Expired
- 2000-11-27 DE DE60026877T patent/DE60026877T2/de not_active Expired - Lifetime
- 2000-11-27 EP EP00980817A patent/EP1248618B1/en not_active Expired - Lifetime
- 2000-11-27 DK DK00980817T patent/DK1248618T3/da active
- 2000-11-27 JP JP2001539448A patent/JP4425514B2/ja not_active Expired - Lifetime
- 2000-11-28 US US09/724,522 patent/US6441002B1/en not_active Expired - Lifetime
-
2002
- 2002-06-26 US US10/180,399 patent/US20020198238A1/en not_active Abandoned
-
2003
- 2003-01-14 US US10/342,379 patent/US20030144327A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2391650C (en) | 2011-01-25 |
| JP2003514859A (ja) | 2003-04-22 |
| US20030144327A1 (en) | 2003-07-31 |
| US6441002B1 (en) | 2002-08-27 |
| EP1248618A4 (en) | 2003-05-14 |
| AU1803101A (en) | 2001-06-04 |
| JP4425514B2 (ja) | 2010-03-03 |
| EP1248618B1 (en) | 2006-03-22 |
| AU776544B2 (en) | 2004-09-16 |
| CA2391650A1 (en) | 2001-05-31 |
| WO2001037833A1 (en) | 2001-05-31 |
| DE60026877D1 (de) | 2006-05-11 |
| US20020198238A1 (en) | 2002-12-26 |
| ES2259295T3 (es) | 2006-10-01 |
| EP1248618A1 (en) | 2002-10-16 |
| ATE320809T1 (de) | 2006-04-15 |
| DK1248618T3 (da) | 2006-07-10 |
| DE60026877T2 (de) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002214505A1 (en) | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives | |
| AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
| AU2002362603A1 (en) | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors | |
| AU2002219322A1 (en) | Closed loop fluid-handing system for well drilling | |
| AU2001244399A1 (en) | Gamma-secretase inhibitors | |
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU2002250394A1 (en) | Rho-kinase inhibitors | |
| WO2001085978A3 (en) | Method for high-throughput lead profiling | |
| AU2001284242A1 (en) | Substituted pyrimidines as selective cyclooxygenase-2 inhibitors | |
| AU3331997A (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
| AU2001261269A1 (en) | 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase | |
| DK1248618T3 (da) | Polymorfe, amorfe og hydratiserede former af 5-chlor-3-(4-methansulfonylphenyl)-6'-methyl-[2,3']bipyridinyl | |
| AU2001251414A1 (en) | Method of detecting carcinomas | |
| AU2001290777A1 (en) | Intelligent voice bridging | |
| WO2000005214A3 (en) | Isoquinolines as urokinase inhibitors | |
| FI20002903A0 (fi) | Bittinopeuden määrittäminen | |
| NO20010568D0 (no) | Substituerte imidazo[1,2a]aziner som selektive inhibitorer for cox-2 | |
| AU2001236052A1 (en) | Urease inhibitors | |
| IT1319240B1 (it) | Procedimento per la oligomerizzazione selettiva dell'etilene. | |
| AU2001294274A1 (en) | Antibody inhibiting VPLF activity | |
| AU2001255090A1 (en) | Cdk inhibitors having 3-hydroxychromen-4-one structure | |
| AU2001258841A1 (en) | Heterocyclic compounds | |
| AU2001283856A1 (en) | Bit error rate estimation | |
| AU2001288092A1 (en) | Method of crystallization | |
| AU2001293207A1 (en) | Nitrogenous heterocyclic compounds |